戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 levels of PAI-1 antigen, PAI-1 activity, and TPA antigen.
2 ivity are associated with increases in total TPA antigen.
3  plate assay), tissue plasminogen activator (tPA) antigen (Ag) and activity (Act), plasminogen activa
4 lues were 9.0 versus 7.4 ng/mL (P<0.001) for tPA antigen and 27.6 versus 23.4 ng/mL (P=0.001) for D-d
5 es in blood flow and local release of plasma tPA antigen and activity (P<0.001 for all) but had no ef
6 de (P<0.001), although coronary sinus plasma tPA antigen and activity concentrations increased only d
7      The area under the curve for release of tPA antigen and activity decreased by 51% and 53%, respe
8 , effectively slowing the clearance of total TPA antigen and explaining in part why high levels of PA
9 n stratified by HT, the relationship between tPA antigen and incident coronary heart disease was simi
10                                              TPA antigen and PAI-1 antigen were highly correlated wit
11                                     Elevated tPA antigen and, to a lesser extent, D-dimer are indepen
12 tigen and tissue-type plasminogen activator (tPA) antigen and activity in 31 patients taking an ACE i
13 ps of elevated tissue plasminogen activator (tPA) antigen and D-dimer with subsequent first coronary
14                          Levels of PAI-1 and tPA antigens, but not other hemostatic factors, were hig
15 ith glucose intolerance, levels of PAI-1 and tPA antigen in men and women (P<.01 for trend) and vWF a
16 n forearm blood flow (P=0.03) and release of tPA antigen (P=0.04) and activity (P<0.001) caused by su
17 activity: tissue-type plasminogen activator (TPA) antigen, plasminogen activator inhibitor-1 (PAI-1)
18                In analyses stratified by HT, tPA antigen remained a consistent marker of increased co
19  risk factors, including C-reactive protein, tPA antigen remained a significant predictor.
20 iod followed by measurement of TPA activity, TPA antigen, TPA/PAI-1, TPA/C1 inhibitor, PAI-1 activity
21 tio in the highest versus lowest quartile of tPA antigen was 3.5 (95% CI, 2.1 to 5.8; P trend <0.001)
22               alpha-Phase clearance of total TPA antigen was faster in subjects with low PAI-1 (t(1/2
23 rance of total tissue plasminogen activator (TPA) antigen, we studied the clearance of active TPA and
24 ltivariate-adjusted geometric mean values of TPA antigen were 6.3 and 7.3 ng/mL among current users a
25                                  Mean plasma tPA antigens were 2.7 microg/mL (tPA infusion, 20 microg
26 -1 antigen and tissue plasminogen activator (TPA) antigen were measured before randomization and on d

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。